Health System

In the first part of our interview, Dr. Charles Lee will explain what this new Oregon law stipulates, the significance of this legislation, and some of the consequences of medication errors due to patient language barriers.

Oncology programs provide the tools needed to improve patient outcomes.

NCPA applauded the Michigan’s House passage of the legislation, which would reform many PBM reimbursement practices in the state.

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.

NCPA lauded the higher reimbursement rate in a statement.

Hospitals employ several strategies for a proactive approach to shortages.

Alternative healing approaches and therapies become increasingly popular among consumers.

In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.

During Women’s History Month, we celebrate the achievements of women in pharmacy practice.

Investigators used MRI scans of the heart to identify whether heart injury was caused by COVID-19 infection.

Pharmacy leaders have leveraged their experience, their role in interdisciplinary teams, and technology to quickly reinvent approaches to manage long-standing issues exacerbated by the pandemic.

The approval of the first-line treatment was granted to Regeneron Pharmaceuticals.

Despite breakthroughs for personalized medicine, barriers still exist in real-world application.

The presentation discussed the pandemic’s effect on medication safety and provided recommendations to hospitals.

What pharmacy needs to know about the transition to the new fee-for-service program in California for Medi-Cal

Pharmacy professionals serving minority populations aim to bridge gaps in health care access.

Vizient provides drug price estimates for pharmaceutical products used across multiple health system settings.

New branding designed to reflect the company’s mission to drive growth through innovation and consistent pursuit to create healthier futures

Results of a study presented in a poster presentation during ASHP Midyear collected data of the available OTC CBD products being sold in Colorado pharmacies.

On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for coronavirus disease 2019 (COVID-19).

Pharmacists can provide education on migraine prophylaxis for better outcomes.

There are a variety of promising and unique medications in different therapeutic areas expected for approval in 2021.

Amid the pandemic, how effectively pharmacists embraced their role as frontline care providers could change the profession forever.

Several key regulatory changes made over the past year affect health-system pharmacists.